GGrantIndex
Sort

21,453 grants matching tuberculosis

Quantitative Design of Multi-drug Regiments for Tuberculosis

$2,475,000
Bree Beardsley Aldridge · Tufts University Boston · DP2 · FY2013 · LM

Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit

$2,464,363
Pablo Tebas · University Of Pennsylvania · UM1 · FY2020 · AI

HPMI: Host Pathogen Mapping Initiative

$2,464,183
Nevan J Krogan · University Of California, San Francisco · U19 · FY2025 · AI

Novel imaging biomarkers to address fundamental controversies in TB pathogenesis

$2,460,000
Sanjay Jain · Johns Hopkins University · DP2 · FY2009 · OD

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease

$2,456,823
Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit

$2,456,647
Roy M Gulick · Weill Medical Coll Of Cornell Univ · UM1 · FY2014 · AI

NEW ANIMAL MODELS FOR TUBERCULOSIS (TB)

$2,455,628
Michelle Linehan · · N01 · FY2007 · AI

Arming the Immune System Against Pathogens

$2,453,989
Harvard University (Sch Of Public Hlth) · P01 · FY2003 · AI

ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)

$2,453,560
Warwick Britton · University Of Sydney · N01 · FY2022 · AI

Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)

$2,451,280
Sarah Fortune · Harvard University D/B/A Harvard School Of Public Health · N01 · FY2024 · AI

Variation in M. tuberculosis in response to host selection

$2,449,750
Sarah M Fortune · Harvard School Of Public Health · DP2 · FY2007 · OD

Structure-based Discovery of Critical Vulnerabilities of Mycobacteria

$2,445,337
James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2019 · AI

Johns Hopkins University Baltimore India Clinical Trail Unit (JHUBI CTU)

$2,442,720
Amita Gupta · Johns Hopkins University · UM1 · FY2025 · AI

Genes And Gene Products As Immunoadjuvants

$2,440,402
Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA

$2,439,613
University Of Kwazulu-Natal · U19 · FY2002 · AI

Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa

$2,438,386
W. Henry Henry Boom · Case Western Reserve University · R01 · FY2017 · AI

TUBERCULOSIS ELIMINATION AND LABORATORY

$2,437,386
Rosalyn Bacon · Georgia State Dept Of Human Resources · U52 · FY2006 · PS

Case Clinical Trials Unit

$2,436,364
Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2023 · AI

Simian Vaccine Evaluation Units

$2,435,221
Mark Lewis · Bioqual, Inc. · N01 · FY2012 · AI

Resources and workforce development for the New England Regional Biosafety Laboratory

$2,435,118
Sam R. Telford · Tufts University Boston · UC7 · FY2023 · AI

New Drug for Treatment of Chronic Bacterial Infection

$2,430,000
Gyanu Lamichhane · Johns Hopkins University · DP2 · FY2011 · OD

Resources and workforce development for the New England Regional Biosafety Laboratory

$2,429,378
Sam R. Telford · Tufts University Boston · UC7 · FY2024 · AI

Structure-based Discovery of Critical Vulnerabilities of Mycobacteria

$2,428,649
James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2020 · AI

Case Clinical Trials Unit

$2,428,514
George Yendewa · Case Western Reserve University · UM1 · FY2025 · AI

CENTERS FOR DISEASE CONTROL AND PREVENTION, TUBERCULOSIS ELIMINATION, LABORATORY

$2,426,426
L Masae Kawamura · San Francisco Department Of Public Health · U52 · FY2012 · PS